AKR1B10 and metabolic dysfunction-associated steatohepatitis: AKR1B10 was upregulated in hepatocytes from patients with NASH (GSE129933) or cirrhosis (GSE136103) compared with hepatocytes from their respective control subjects (Supplementary Figure S3B,C).